HT
PDLI

HAP Trading’s PDL BioPharma, Inc. PDLI Stock Holding History

HAP Trading’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,000
Closed -$10K – 1406
2016
Q4 		$10K Sell
10,000
-2,500
-20% -$6.98K ﹤0.01% 849
2016
Q3 		$5K Buy
+12,500
New +$39.7K ﹤0.01% 1046

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

HAP Trading's PDLI Position: Q4 2014 in Review

HAP Trading sold out of PDL BioPharma, Inc. (PDLI) in Q4 2014, closing a stake of 33,530 shares — an estimated $250K sold.

HAP Trading first reported a position in PDLI in Q1 2014 and held it in 2 quarters. The position peaked at $1.46M in Q1 2014. 223 funds tracked by Wall St. Rank hold PDLI as of Q4 2014.

  • HAP Trading reported no remaining PDL BioPharma, Inc. position as of Q4 2014 after selling out during the quarter.
  • HAP Trading sold 33,530 PDL BioPharma, Inc. shares in Q4 2014, an estimated $250K.
  • HAP Trading first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 2 quarters.
  • HAP Trading's PDL BioPharma, Inc. position peaked at $1.46M in Q1 2014.
  • 223 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2014.

Based on HAP Trading's 13F filing for Q4 2014, filed 13 Feb 2015.